BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19053207)

  • 1. Emerging applications of anticytokine vaccines.
    Delavallée L; Assier E; Semerano L; Bessis N; Boissier MC
    Expert Rev Vaccines; 2008 Dec; 7(10):1507-17. PubMed ID: 19053207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination with cytokines in autoimmune diseases.
    Delavallée L; Assier E; Denys A; Falgarone G; Zagury JF; Muller S; Bessis N; Boissier MC
    Ann Med; 2008; 40(5):343-51. PubMed ID: 18484346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.
    Link A; Bachmann MF
    Immunotherapy; 2010 Jul; 2(4):561-74. PubMed ID: 20636009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination strategies based on the mimotope concept.
    Szalai K; Jensen-Jarolim E; Pali-Schöll I
    G Ital Dermatol Venereol; 2008 Apr; 143(2):95-104. PubMed ID: 18833036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cytokine vaccination: a new biotherapy of autoimmunity?
    Semerano L; Assier E; Boissier MC
    Autoimmun Rev; 2012 Sep; 11(11):785-6. PubMed ID: 22349621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune diseases are connected with disturbances in cytokine synthesis, and therapy with IFN-gamma blockers is their main pathogenetic treatment.
    Skurkovich B; Skurkovich S
    Ann N Y Acad Sci; 2007 Aug; 1109():167-77. PubMed ID: 17785303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Number of vaccinations performed and immunological system].
    Bucholc B; Górska P; Janaszek-Seydlitz W
    Przegl Epidemiol; 2011; 65(4):629-34. PubMed ID: 22390051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines against non-communicable diseases.
    Röhn TA; Bachmann MF
    Curr Opin Immunol; 2010 Jun; 22(3):391-6. PubMed ID: 20338740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.
    Bizzini B; Drouet B; Zagury D; Abitbol M; Burny A; Boissier MC
    Immunotherapy; 2010 May; 2(3):347-65. PubMed ID: 20635900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and emerging vaccination strategies for prevention and treatment of dermatological diseases.
    Walden P; Sterry W
    Expert Rev Vaccines; 2004 Aug; 3(4):421-31. PubMed ID: 15270647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-toxic immunogens for therapeutic anticytokine vaccines.
    Zagury D; Le Buanec H; Bizzini B; Gallo RC
    IDrugs; 2001 Oct; 4(10):1161-6. PubMed ID: 15957085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunity: induction, dissemination, and effector functions.
    Brandtzaeg P
    Scand J Immunol; 2009 Dec; 70(6):505-15. PubMed ID: 19906191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active and passive anticytokine immune therapies: current status and development.
    Le Buanec H; Bensussan A; Bagot M; Gallo RC; Zagury D
    Adv Immunol; 2012; 115():187-227. PubMed ID: 22608260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New vaccination technology for endogenous antigen-derived ailments.
    Barabas AZ; Cole CD; Barabas AD; Bahlis NJ; Lafreniere R
    IDrugs; 2008 Feb; 11(2):111-5. PubMed ID: 18240096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cytokine vaccination in autoimmune diseases.
    Delavallée L; Duvallet E; Semerano L; Assier E; Boissier MC
    Swiss Med Wkly; 2010; 140():w13108. PubMed ID: 21043003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market.
    Huang CJ; Lowe AJ; Batt CA
    Appl Microbiol Biotechnol; 2010 Jun; 87(2):401-10. PubMed ID: 20422181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity, alloimmunization and immunotherapy of AIDS.
    Bourinbaiar AS; Abulafia-Lapid R
    Autoimmun Rev; 2005 Jul; 4(6):403-9. PubMed ID: 16081032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.
    Radosević K; Rodriguez A; Lemckert A; Goudsmit J
    Expert Rev Vaccines; 2009 May; 8(5):577-92. PubMed ID: 19397415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the development of therapeutic anti-cytokine antibodies.
    Reichert JM
    Drug Discov Today; 2004 Apr; 9(8):348. PubMed ID: 15081960
    [No Abstract]   [Full Text] [Related]  

  • 20. Immune therapies of autoimmune diseases: are we approaching a real cure?
    Chatenoud L
    Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.